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Uric acid nephrolithiasis (UAN) is a common disease with an established genetic component that presents a complex
mode of inheritance. While studying an ancient founder population in Talana, a village in Sardinia, we recently
identified a susceptibility locus of ∼2.5 cM for UAN on 10q21-q22 in a relatively small sample that was carefully
selected through genealogical information. To refine the critical region and to identify the susceptibility gene, we
extended our analysis to severely affected subjects from the same village. We confirm the involvement of this region
in UAN through identical-by-descent sharing and autozygosity mapping, and we refine the critical region to an
interval of ∼67 kb associated with UAN by linkage-disequilibrium mapping. After inspecting the genomic sequences
available in public databases, we determined that a novel gene overlaps this interval. This gene is divided into 15
exons, spanning a region of ∼300 kb and generating at least four different proteins (407, 333, 462, and 216 amino
acids). Interestingly, the last isoform was completely included in the 67-kb associated interval. Computer-assisted
analysis of this isoform revealed at least one membrane-spanning domain and several N- and O-glycosylation
consensus sites at N-termini, suggesting that it could be an integral membrane protein. Mutational analysis shows
that a coding nucleotide variant (Ala62Thr), causing a missense in exon 12, is in strong association with UAN
( ). Moreover, Ala62Thr modifies predicted protein secondary structure, suggesting that it may have aPp .0051
role in UAN etiology. The present study underscores the value of our small, genealogically well-characterized,
isolated population as a model for the identification of susceptibility genes underlying complex diseases. Indeed,
using a relatively small sample of affected and unaffected subjects, we identified a candidate gene for multifactorial
UAN.
Introduction
Nephrolithiasis is a common multifactorial disorder of
unknown etiology, which is characterized by the pres-
ence of stones in the urinary tract and known genetic
involvement (Jaeger 1996; Curhan et al. 1997; Baggio
1999; Scheinman 1999). Kidney stones are estimated to
affect 10% of the population (Serio and Fraioli 1999;
Rivers et al. 2000). The major classes of stones are cal-
cium oxalate, calcium phosphate, and uric acid. Uric
acid nephrolithiasis (UAN [MIM 605990]), which occurs
when the urine becomes overly concentrated with uric
acid that may form small crystals (and, subsequently,
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stones), accounts for 20% of all stones. Every year a
considerable number of people are hospitalized for the
disease. An improved understanding of the genetic fac-
tors that contribute to the development of this disorder
will lead to better diagnosis, treatment, and prevention
and will also help to stem, or even to reverse, the rise
in prevalence of this disease.
In humans and some primates, a renal-hematic urate
homeostasis system was developed as a consequence of
evolutionary loss of hepatic uricase present in other
mammalian species (Wu et al. 1989, 1992; Abramson
and Lipkowitz 1990). Uric acid is the end product of
purine metabolism: two-thirds of daily production is
excreted by the kidneys and one-third by the gastro-
intestinal tract (Roch-Ramel and Guisan 1999). Hy-
peruricemia (hyperuricosuria) can occur when there is
excessive dietary consumption of purines from meat and
fish or when there is altered urate elimination. Insight
into the nature of urate homeostasis was derived from
a recently identified renal urate–anion exchanger reg-
ulating blood urate levels (Enomoto et al. 2002). The
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molecular basis of urate handling by the human kidney
is not yet clear, but new knowledge may come from the
study of associated diseases, such as UAN.
A powerful approach to mapping complex disease
genes is to study isolated, founder populations, in which
genetic heterogeneity and environmental noise are likely
to be reduced and where a substantial proportion of
affected individuals are likely to share susceptibility var-
iants identical by descent (IBD) from common ancestors
(Wright et al. 1999; Peltonen et al. 2000). For our stud-
ies, we have selected residents of Talana, a particularly
secluded village in Sardinia. This small, isolated pop-
ulation is characterized by higher prevalence of UAN
than is seen in the rest of the island. The disease shows
familial clustering in Talana, although the transmission
of UAN does not follow a simple Mendelian inheritance
pattern. Clinical studies have shown that other factors
(such as low urinary pH and high levels of uricosuria)
are present in these patients with UAN, thereby con-
firming the multifactorial etiology of the disease.
In a previous study, we performed a multistep ge-
nomewide search in several families belonging to a sin-
gle nine-generation genealogical tree comprising 37 in-
dividuals with UAN. We identified a susceptibility locus
on the chromosomal region 10q21-q22, with the highest
evidence at marker D10S1652 (Ombra et al. 2001). We
now describe the fine mapping of the identified critical
region, using more-severely affected individuals from
the same village. The fine mapping led to the detection
of a 67-kb interval, around marker D10S1652, that is
statistically associated with UAN. We identified a novel
gene, called “ZNF365,” that encodes at least four dif-
ferent protein isoforms spanning this region. Interest-
ingly, one of the isoforms resides entirely within the 67-
kb interval. In addition, in this isoform, we identify a
missense amino acid variant that alters the protein sec-
ondary structure and is associated with the disease,
making it a strong candidate predisposing factor.
Material and Methods
Genealogical Data and Sample Collection
All individuals participating in the study were among
the 1,200 inhabitants of Talana, a village in east-central
Sardinia that is characterized by slow population growth
and high levels of endogamy and inbreeding (Wright et
al. 1999; Angius et al. 2001). Historical and archival
data allowed the reconstruction of the genealogy of each
individual as far back as the 17th century. Haplotype
and phylogenetic analyses of the Y chromosome and
characterization of mtDNA haplogroups were used to
determine the number of ancestral founders. Approxi-
mately 80% of the present-day population derives from
8 paternal and 11 maternal ancestral lineages. All ge-
nealogical data, as well as phenotypic and genetic data,
are stored in relational databases. The bioinformatic
framework comprises several algorithms that allow in-
terrogation and extraction of data for analyses.
Clinical features of the sample and details of recruit-
ment and diagnostic procedures have been described
elsewhere (Ombra et al. 2001). In brief, we collected
information on age at diagnosis, medications, hospital
admissions, and family history of kidney stones. UAN
diagnoses were clinically confirmed by accurate physical
examination and by renal ultrasonography. The original
patient list included 134 affected subjects. For the pres-
ent study, we selected 62 patients (mean age 58.4 years)
with severe UAN. Disease severity was established on
the basis of the following criteria: age at onset, number
of episodes of abdominal colic, and number and di-
ameter of expelled stones. Affected subjects with mild-
to-moderate disease symptoms were excluded from the
study. We identified 94 control subjects, who were ex-
amined by use of ultrasonography to exclude individuals
with asymptomatic disease. The mean age at observation
of unaffected controls was ∼50 years, which meant that
those with a predisposition to disease were very likely
to have developed stones, given that the mean age at
onset for affected subjects is ∼38 years. All subjects gave
written informed consent, and all samples were taken in
accordance with the Helsinki declaration.
SNP Genotyping
To find common SNPs in the UAN critical region, we
used Sequencher software to perform an extensive align-
ment of genomic sequences deposited in public databases.
The screening panel included 10 unrelated Talana sub-
jects. PCR amplicons of 800–1,000 nt containing the se-
lected putative polymorphisms were designed using Oligo,
version 4.0, software. PCR were prepared using 50 ng of
genomic DNA template, 0.5 mM of each PCR primer, 1.5
mM MgCl2, 0.2 mM of each dNTP, 0.5 U Taq polymer-
ase, and the buffer recommended by the supplier (Amer-
sham), in a final volume of 25 ml. Thermocycling started
with a single 2-min denaturation step at 94C, followed
by 35 cycles of 30 s denaturation at 94C, 30 s annealing
at melting temperature (MT), and a 45-s extension at
72C. One final 7-min extension step at 72C was added.
Samples were then sequenced using the Big Dye Ter-
minator Ready Reaction kit (Applied Biosystems). Se-
quencing reactions were performed on a 9700 Thermal
Cycler (Applied Biosystems) for 25 cycles of 95C for
10 s, MT for 5 s, and 60C for 2 min. After the se-
quencing, each reaction was precipitated with isopro-
panol to remove excess dye terminators. Sequencing of
the products was performed on the ABI Prism 3100 Ge-
netic Analyzer (Applied Biosystems). Polymorphismswere
detected by multiple alignments of sequences, using the
program Autoassembler (Applied Biosystems).
Mutational analysis of all 15 exons of the identified
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candidate gene was performed. Each PCR amplicon was
designed for scanning of ZNF365 exons 1–15, including
intron/exon boundaries. All PCRs and sequence reac-
tions were performed as described above.
Genotyping of SNPs was performed by dot-blot hy-
bridization of PCR products, comprising the polymor-
phisms, with short allele-specific oligonucleotide probes,
using an established protocol (Ristaldi et al. 1989). To
estimate the frequency of the identified variant Ala62Thr
in an outbred population, we genotyped 200 individuals
from other parts of Sardinia. The primers used to detect
the Ala62Thr variant were 5′-CTCCACTCCACCTTTT-
TAAG-3′ and 5′-GCTGACATTGGTACTTACTG-3′.
Statistical Analysis
From the available genealogical information, we iden-
tified all pairwise connections between all pairs of affected
and unaffected subjects and estimated the kinship coef-
ficients, the number of meiotic steps separating each pair,
and the nine condensed identity coefficients using an al-
gorithm developed by Abney et al. (2000). To perform
formal kinship analysis of our cases and controls, we first
checked that there was not a significant difference in the
distributions of number of meiotic steps between the af-
fected and unaffected subjects, thus ensuring an unbiased
sample selection. Differences between affected and un-
affected subjects in kinship and identity coefficients were
tested through 10,000 resampling cycles.
The genealogical information allows the identification
of all common ancestors of the 62 affected individuals,
linked in an extended complex pedigree comprising 710
subjects. Simwalk2 (Sobel and Lange 1996) was used in
the linkage analysis to compute IBD-sharing statistics on
the basis of the degree of marker-allele clustering among
affected relatives in the extended pedigree. Homozygosity
mapping was performed with the program Mapmaker/
Homoz (Kruglyak et al. 1995), providing real inbreeding
coefficients, estimated from the whole genealogy, for the
parents of affected subjects or affected sibs.
Association analyses for a single locus were performed
with the DISEQ program (Terwilliger 1995), that, apply-
ing a likelihood-ratio test for linkage disequilibrium (LD)
with only 1 df, irrespective of the number of alleles at a
given marker, does not require correction for multiple
alleles. We also performed 10,000 Monte Carlo simula-
tions to assess empirical significance of the departure of
observed values from the expected values in the contin-
gency table. Each simulation generated a table having the
same marginal totals as the one under consideration, and
empirical significance was derived by counting the num-
ber of times that a x2 value associated with the real table
was achieved by the randomly simulated data. Although
multiple tests performed for each marker increase the
false-positive rate, a Bonferroni correction of nominal val-
ues would likely be overly conservative, since the tests are
highly correlated. It is unclear what multiple-test correc-
tion would be more appropriate.
We also performed multilocus haplotype analysis for
association, to minimize the chance of type I error,
thereby providing stronger statistical support for the re-
gion. We used Simwalk2 to generate the haplotypes with
the highest likelihood, using all genealogical information
about the subjects and all typed relatives. Differences in
frequencies of haplotypes between cases and controls
were tested for all possible haplotypes of adjacent mark-
ers. Only common haplotypes (frequency 15% in the
whole sample) were compared between cases and con-
trols. We performed 100,000 Monte Carlo simulations
to evaluate empirical significance.
cDNA Clones
KIAA0844 was kindly provided by Kazusa DNA Re-
search Institute. ZNF365A, ZNF365C, and ZNF365D
cDNA sequences were obtained by RT-PCR/TOPO-clon-
ing vector (Invitrogen) strategy, using pairs of primers
designed in different exons of the gene in human kidney
RNA (Clontech) and 5′– and 3′–rapid amplification cDNA
end (RACE) strategy performed with human kidney Mar-
athon-Ready cDNA kit. ZNF365B cDNA sequence was
obtained by sequencing the cDNA clones 3069791 and
4821260 from the IMAGE Consortium.
Bioinformatic Predictions
Different modeling programs for predicting potential
transmembrane domains, all with default parameters,
were used: DAS (Cserzo et al. 1997), TopPred 2 (von
Heijne 1992), TMPred (Hofmann and Stoffel 1993),
PRED-TMR2 (Pasquier and Hamodrakas 1999), TMAP
(Persson and Argos 1996). The a-helical predictions
were obtained using the SecStr package. This package
makes use of an algorithm that combines the results of
the secondary structure prediction of six different meth-
ods (Burgess et al. 1974; Lim 1974; Dufton and Hider
1977; Nagano 1977; Chou and Fasman 1978; Garnier
et al. 1978). The coiled-coil segments were predicted
using two different programs: COILS (Lupas et al. 1991)
and PAIRCOILS (Berger et al. 1995).
RNA Expression Studies
A human multiple-tissue northern blot (Clontech) was
hybridized with ZNF365A, -B, -C, and -D transcripts.
The northern blot was prehybridized, hybridized, and
washed according to the manufacturer’s instructions
(Clontech).
RT-PCR
For the expression pattern of the ZNF365 gene, RT-
PCR was performed on a normalized cDNA panel
(Clontech). Primers used to amplify the four transcripts
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Figure 1 Physical and transcriptional maps. Markers of the physical map are indicated above the solid bar representing genomic DNA;
orientations of genes are indicated (arrows). a, Physical and transcriptional map of the 1.1-Mb region corresponding to the UAN critical region.
The known microsatellites markers are D10S1719, D10S1652, and D10S1640. All genes and ESTs located in this region are shown and their
mapping position is in scale. b, SNP map of the region around marker D10S1652. Allele frequencies in the Talana population for all SNPs are
available from the authors.
were as follows: ZNF365A (5′-TCCTCAAATAGGAA-
GCCC-3′ and 5′-AAATTAGCTGAGGGGAAGGT-3′ in
exons 4 and 5, respectively); ZNF365B (5′-AACAACT-
GAGTACCTGCCAT-3′ and 5′-TCGCCTGGTGTGCC-
AAAATG-3′ in exons 6 and 7, respectively); ZNF365C
(5′-AACAACTGAGTACCTGCCAT-3′ and 5′-GGAGT-
CCTAAGACGTCCTTC-3′ in exons 6 and 13, respec-
tively); and ZNF365D (5′-CTATGCAGGAGTTTCAA-
TTC-3′ and 5′-GGAGTCCTAAGACGTCCTTC-3′ in ex-
ons 12 and 13, respectively). Primers for the G3PDH
gene were obtained from Clontech. All primers were
located in exons, and the included introns were suffi-
ciently large that amplification from genomic DNA
yielded either no PCR product or an easily distinguish-
able product. PCRs were performed using 1 ml of cDNA
in a 10-ml PCR volume containing 1# PCR buffer
(Amersham), 0.2 mM dNTPs, 0.5 U AmpliTaq poly-
merase (Amersham), and 0.5 mM each of the described
primers. Using a DNA Thermal Cycler 9700 (Applied
Biosystems), we performed 40 cycles of amplification
for ZNF365A, -B, and -D transcripts, 45 cycles for
ZNF365C, and 25 cycles for G3PDH. Cycles consisted
of 30 s at 94C, 30 s at MT, and 30 s at 72C.
For gene characterization, RT-PCR was performed us-
ing 0.5-mg samples of human kidney (Clontech), adrenal
gland (Clontech), and blood mRNA that were reverse-
transcribed in a 50-ml reaction mixture containing 1#
RT buffer (20 mM Tris-HCl [pH 8.4], 50 mM KCl, and
2.5 mM MgCl2), 10 mM DTT, 0.5 mM dNTP, 0.2 mg
random hexamers (Roche), and 200 U SuperScript RT
(Invitrogen). After a 60-min incubation at 37C, 1 mg
DNase-free RNase was added and incubated 10 min at
37C. The cDNA formed was extracted twice with phe-
nol/chloroform/isoamylalcohol (25:24:1). The cDNA
was then precipitated overnight with 1:10 vol 3 M so-
dium acetate (pH 5.2) and 2.5 vol ethanol; 10-ng sam-
ples of each cDNA were used as templates in 25-ml
PCRs containing 1# PCR buffer (Amersham), 0.2 mM
dNTPs, 0.5 U AmpliTaq polymerase (Amersham), and
0.5 mM each of the primer sequences derived from cDNA.
Using a DNA Thermal Cycler 9700 (Applied Biosys-
tems), we performed amplification in 40 cycles of 30 s
at 94C, 30 s at MT, and 45 s at 72C.
5′- and 3′-RACE strategy was performed using 5 ml
Marathon human kidney cDNA (Clontech), 1# PCR
buffer (Amersham), 0.2 mM dNTPs, 1.0 U AmpliTaq
polymerase (Amersham), and 0.5 mM each of the gene-
specific primer and AP1 primer (Clontech) in a final vol-
ume of 50 ml. Twenty-five amplification cycles were per-
formed using 30 s at 94C, 20 s at MT, and 4 min at
68C. Nested PCRs were performed with the same pro-
tocol described for the first PCRs, using 1/250 of the first
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PCRs and gene-specific primers 2 and AP2 (Clontech), in
a final volume of 50 ml. Thirty amplification cycles were
performed at 30 s at 94C, 20 s at MT, and 4 min at
68C. Aliquots of the products of the first and second
PCRs performed with different gene-specific primers were
run on agarose gel and were blotted on nylon membrane,
according to the manufacturer’s instructions (Amersham).
Membranes were hybridized with a PCR product includ-
ing exons 2–5 of the ZNF365D transcript. Positive PCR
products were cloned in TOPO-vector (Invitrogen) and
were sequenced with M13 forward and reverse primers,
as described above.
Results
Linkage Analysis
We reported elsewhere the identification, in a 2.5-cM
region flanked by markers D10S1719 and D10S1640, of
a susceptibility locus for UAN on 10q21-q22 (Ombra et
al. 2001). For the present study, we reconstructed the
genealogical relationships of 62 severe cases and 94 nor-
mal subjects and tested the identified region through non-
parametric linkage and autozygosity-mapping analyses.
Nonparametric linkage analysis, based on IBD shar-
ing, was performed on a large pedigree connecting all
affected subjects. Cases displayed greater IBD sharing
than would be expected by chance in the region, where
allele-sharing statistics A, C, and D of Simwalk2 resulted
in P values !.05, again with a peak value at marker
D10S1652. From formal kinship analysis, the UAN
cases were found to have higher mean kinship coeffi-
cients than those of unaffected subjects (0.0150 vs.
0.0139), and the difference between the two groups was
highly significant (empirical , estimated fromP ! .0001
resampling procedure). UAN cases were also found to
have a greater probability of sharing all four alleles IBD
(condensed identity coefficient D1) and both alleles IBD
(condensed identity coefficient D7) than did controls (em-
pirical , estimated from resampling proce-P ! .0001
dure). Thus, we performed autozygosity mapping that
yielded multipoint LOD scores 13.0 in the region flanked
by D10S1652 and D10S1719. These results confirm
the involvement of the region in UAN in this enlarged
sample.
Transcriptional Map of UAN Locus
We obtained a consensus genomic sequence of the 1.1-
Mb region, corresponding to the identified 2.5-cM crit-
ical interval, by alignment of partial sequences available
in different databases. To identify the disease-suscepti-
bility gene by use of the candidate gene approach, we
developed a transcriptional map of this region. Using
several sequence-analysis tools and database-mining
procedures, we determined that the 1.1-Mb interval con-
tained at least six novel genes, including two unchar-
acterized genes (significant similarity with proteins of
known or inferred function) and four orphan genes (fig.
1A). The modulator-recognition factor 2 (MRF-2) gene
is the ortholog of the mouse Desrt gene. Mice homo-
zygous for mutations in this gene were retarded in their
mental and sexual development, with transient immune
abnormalities (Lahoud et al. 2001). The rhotekin-like
(RTKN-L) gene is a homolog of RTKN gene, an inhib-
itor of r-GTPase activity localized on chromosome 2 (Fu
et al. 2000). The ESTs 603251916F1 (UniGene cluster
Hs.252954), hd42c05.x1, and 603040095F1, as well as
KIAA0844 cDNA (Nagase et al. 1998), exhibit no
significant similarity to any other protein deposited
in public databases. In the absence of functional as-
signment, it is not possible to know which one of these
six genes may have a role in UAN, although the EST
603040095F1 is the closest to marker D10S1652, which
is associated with UAN.
Fine Mapping
To fine map the identified locus and to refine the crit-
ical region, we performed LD-mapping analysis, gen-
erating an SNP map around the D10S1652 marker pre-
viously found to be significantly associated with UAN
(Ombra et al. 2001) in the village of Talana. Comparison
among genomic sequences deposited in various data-
bases allowed us to identify 39 new SNPs in this re-
gion (fig. 1B). The sequence analysis of PCR amplicons
(∼800–
1,000 bp) containing the selected putative polymor-
phisms showed an average nucleotide diversity, of 0.2%
(one variable site every 500 bp), across the region. We
performed association analysis using a subset of 11
SNPs evenly spaced throughout the region, 2 newly
localized microsatellite markers (AFM214zb6 and
AFMA234wc5), and 3 markers that were included
in our previous study (D10S1719, D10S1652, and
D10S1640). This set of markers was genotyped in 62
affected and 94 unaffected subjects and in their close
relatives, to infer the most likely phase and, hence, hap-
lotypes. For affected subjects, 112 complete haplotypes
were reconstructed (90% of the theoretical maximum
[124]), and, for unaffected subjects, 142 complete hap-
lotypes were reconstructed (76% of the theoretical max-
imum [188]).
At the nominal significance level of !.05, two markers
(namely, D10S1652 and pSNP3A) were associated with
UAN in the likelihood-ratio test and were also signifi-
cantly associated in the empirical test performed with
the use of 10,000 Monte Carlo simulations (table 1).
Since the case-control sample included related individ-
uals (thereby increasing the type I error rate of the as-
sociation test), we repeated the tests while controlling
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Table 1
Results of the Association Tests
Marker
Position
(kb)
Frequency
in Controls
Frequency
in Cases Pa Empirical Pb,c Pd Empirical Pc,e
D10S1719 0 … … ns ns ns ns
SNP NG3 4 .66 .54 ns ns ns ns
SNP 9 12 .74 .79 ns ns ns ns
SNP 10 30 .76 .82 ns ns ns ns
SNP 11 46 .77 .82 ns ns ns ns
SNP AV70 85 .68 .76 ns ns ns ns
D10S1652 90 … … .0006 .0004 .0009 .0031
pSNP 3A 100 .68 .53 .0123 .0073 .0146 .0075
SNP AV72 113 .87 .91 ns ns ns ns
SNP 14 120 .87 .90 ns ns ns ns
AFM214zb6 175 … … .0213 ns ns ns
SNP N 216 .52 .49 ns ns ns ns
SNP 1 260 .72 .64 ns ns ns ns
SNP 7 527 .69 .57 ns ns ns ns
AFM234wc5 850 … … ns ns ns ns
D10S1640 1055 … … ns ns ns ns
NOTE.—All markers tested were in the 1.1-Mb region, and the frequency of the most common allele
for each SNP is shown. Two-point–association analysis was performed, with underrepresented alleles
(!2.5% in the combined sample) grouped together; ns p not significant.
a Two-point association test comparing 62 affected and 94 unaffected subjects, including related indi-
viduals. The tests were performed with the DISEQ program.
b Empirical P values obtained by performing 10,000 Monte Carlo simulations between the 62 affected
and 94 unaffected subjects.
c Empirical P values obtained by performing repeated simulations to generate tables having the same
marginal totals as the one under consideration, and counting the number of times that a x2 value associated
with the real table was achieved by the randomly simulated data.
d Two-point association test performed between 34 cases and 53 controls separated by more than three
meiotic steps (independent sample).
e Empirical P values obtained by performing 10,000 Monte Carlo simulations in the independent case-
control sample.
for close relationships among the subjects. From the
complete set, a smaller sample of individuals was created
by selecting cases and controls separated by more than
three meiotic steps, without regard to genotypes. The
resulting selected sample consisted of 34 cases and 53
controls separated by an average of eight meiotic steps.
Also, in this cohort, the same two markers provided
significant evidence of association, with the highest sig-
nificance at marker D10S1652 ( ; empiricalPp .0009
) (table 1). Haplotype frequencies in thePp .0031
whole sample and in the selected independent sample
are shown in figure 2. The haplotype flanked by SNPs
NG3 and AFM214zb6 (fig. 2) was the most common
core haplotype among patients with UAN and was more
frequent in cases than in controls. The four most com-
mon extended haplotypes (haplotypes A, B, C, and D)
containing this core haplotype were observed among
cases. In the selected sample, we performed haplotype-
based LD-mapping analysis, in which we considered
only the 11 biallelic polymorphisms, because STRPs pre-
sent higher mutation rates (which may impede detection
of ancient LD segments). The analysis was performed
by testing all possible haplotypes of adjacent markers,
using windows of variable sizes. Haplotype-association
analysis identified a significant core region of 67 kb,
flanked by SNPAV72 and SNP11 (fig. 2) and associated
with disease susceptibility (empirical ).P ! .05
When we consider only individuals with complete
haplotypes (56 cases and 71 controls), the most common
67-kb risk haplotype in patients with UAN was observed
in 40 cases (71.4%), compared with 35 controls (49.3%).
Homozygotes accounted for 32.5% (13/40) of these
cases. The 67-kb haplotype was associated with a sig-
nificantly increased risk of UAN (odds ratio [OR] 2.57;
95% CI 1.15–5.80).
Molecular Characterization of the UAN-Susceptibility
Gene
All previously described genes except the EST
603040095F1 were located outside the 67-kb associated
interval; therefore, none of them were further analyzed.
We focused our interest on the novel gene corresponding
to this EST. To characterize the 5′ and 3′ regions, we
performed RT-PCR and used RACE strategies, starting
from the coding region. An extensive gene, spanning a
300-kb region and overlapping the 67-kb associated in-
terval, was disclosed. Genomic and cDNA sequence com-
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Figure 2 Haplotype frequencies in the whole sample (all sample) and in the subsample obtained controlling for close relatedness among
subjects (selected sample). Haplotype-association tests performed in the selected sample showed that the haplotype between SNP AV70 and
pSNP 3A (dark gray) was significantly associated with the disease. The haplotype flanked by SNP NG3 and AFM214zb6 (light gray) was more
frequent in cases than in controls. Microsatellite markers were not considered in the haplotype-association tests. Microsatellite alleles are shown
in italics. The same allele at marker D10S1652 was always present in the associated haplotype (Ombra et al. 2001).
parisons showed that the gene consists of 15 exons and
includes the EST 603040095F1 within the core interval
and the KIAA0844 sequence outside it (figs. 1 and 3).
In the human kidney, we identified a complex pattern
of alternative splicing and transcriptional start sites that
generated different proteins of 407, 333, 462, and 216
amino acids, respectively (fig. 3).
ZNF365A transcript.—This 1,798-bp transcript, con-
taining the entire 1,224-bp ORF, was obtained by RT-
PCR based on the information of the Kazusa DNA Re-
search Institute for KIAA0844 cDNA and was deposited
in the EMBL Nucleotide Sequence Database (Nagase et
al. 1998). It was split in 5 exons encoding a putative
protein of 407 amino acids with a molecular weight of
46,558 Da, and its putative promoter region contains a
CpG island. The N-terminal region of this protein
(amino acids 26–51) harbors the classical zinc finger
domain of C2H2 family (fig. 4). This domain is found
in numerous nucleic acid–binding proteins, but some
investigators have suggested that it could be used in pro-
tein-protein interaction and in membrane association
(Laity et al. 2001). This gene was renamed “zinc finger
protein 365” (ZNF365A) by the HUGO Gene Nomen-
clature Committee. Secondary structure predictions for
this protein, which were created using various programs,
strongly suggest the presence of four a-helical coiled-coil
domains that are found in various protein families and
frequently used as oligomerization motifs (Jorde et al.
2000). Northern analysis showed that the transcript was
ubiquitously expressed, with a 5-kb transcript present
at low levels in all adult human tissues examined and
with slightly higher levels in the brain (data not shown).
ZNF365B transcript.—This 1,671-bp transcript, was
identified by EST analysis and cDNA clone sequencing.
The 333–amino acid protein was identical to the
ZNF365A protein in the N-terminal region (exons 1–3)
containing the zinc finger domain and coiled-coil seg-
ments, but it diverged at C-terminal region (exons 6–7)
(figs. 3 and 4).
ZNF365C transcript.—The ZNF365C transcript was
isolated by RT-PCR using different combinations of
primers anchored in different exons of the KIAA0844
transcript and EST 603040095F1. This 3,376-bp tran-
script overlapped the critical region, showing that the
KIAA0844 transcript and the EST 603040095F1 belong
to the same gene. ZNF365C has the first four exons and
the same CpG island promoter as the ZNF365B tran-
script outside of the critical region and four different
terminal exons (9, 13, 14, and 15). Exons 13, 14, and
15 are located in the associated region (fig. 3). Moreover,
the encoded 462–amino acid protein was similar to
ZNF365B protein but had a different C-terminal region.
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Figure 3 Genomic structure of ZNF365, showing alternative splicing and alternative start sites that generate four different transcripts.
Initiation codons (ATG) and stop codons (TAA or TGA) are shown for all isoforms. Two different promoters, CpG island (P1) and TATA box
(P2) are indicated (arrows). Exons used for each transcript (colored boxes), together with the associated 67-kb interval, are indicated. The
Ala62Thr missense variant found in the ZNF365D isoform is shown. Exons 1–5 and 10–13 identified the KIAA0844 transcript and the EST
603040095F1, respectively.
Computer-assisted analysis of this isoform, based on
transmembrane domain prediction, revealed at least two
membrane-spanning domains in this novel C-terminal
region from amino acid 344 to 395, suggesting that it
could be an integral membrane protein (fig. 4).
ZNF365D transcript.—The ZNF365D transcript spans
a region of ∼150 kb and uses its own specific TATA-
box promoter, differing from ZNF365A, -B, and -C,
which use the same CpG island promoter. Interestingly,
all the transcript coding exons are included in the 67-
kb associated interval (fig. 3). The full-length cDNA was
obtained by 5′- and 3′-RACE strategies. The composite
2,695-bp cDNA sequence encoded a 216–amino acid
protein completely different from the proteins encoded
by ZNF365A and -B but identical to ZNF365C in the
C-terminal region (figs. 3 and 4). Prediction analysis re-
vealed a strong transmembrane domain in this isoform
at positions 126–149, suggesting that, like ZNF365C,
it could be an integral membrane protein with N-termini
outside the cell. In the noncytosolic portion, several po-
tential modification sites were detected, including pos-
sible N- and O-linked glycosylation sites at Asn-20, Asn-
82, Thr-88, Thr-89, Ser-90, Ser-91, Ser-93, and Thr-97,
suggesting that this outer membrane protein portion
may be glycosylated.
When all isoforms of 407, 333, 462, and 216 amino
acids were used as a query, BLAST algorithms revealed
no significant homology to other proteins deposited in
public databases, suggesting that they could be a new
class of proteins. ZNF365B, -C, and -D revealed no
signal by northern analysis. RT-PCR was performed to
study the expression profile of the ZNF365 gene in dif-
ferent human tissues, using a normalized cDNA panel.
Significant expression was found in brain for ZNF365A
transcript, as was observed in northern blot analysis
(data not shown), and low-level expression occurred in
other tissues. ZNF365B transcript was detected in pla-
centa and at low levels in lung and liver, ZNF365C was
detected only in kidney and pancreas, and ZNF365D
was detected in placenta, lung, liver, kidney, and pan-
creas (fig. 5).
Identification of a Specific ZNF365D Susceptibility
Variant
To test our hypothesis that ZNF365 may have a role
in UAN, we focused on detecting possible sequence var-
iations that alter the level or activity of the coded pro-
teins, ultimately contributing to the development of the
clinical phenotype. We resequenced all exons ofZNF365
and part of the intronic regions encompassing the critical
region. Resequencing was performed in eight patients
who carried the putative nephrolithiasis-susceptibility
haplotype. Of special interest was the identification of
two variants that cause missense in exon 5 (ZNF365A
transcript), resulting in serine/alanine amino acid substi-
tution (variant Ser337Ala), and in exon 12 (ZNF365D
transcript), resulting in alanine/threonine amino acid
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Figure 4 Alignment of the amino acid sequences of ZNF365 protein isoforms. Amino acids are indicated by single-letter codes. Identical
amino acids are indicated (gray boxes). The C2H2 zinc finger domain (solid line) and the coiled-coil segments (dotted line) are indicated. The
predicted transmembrane domains are framed. ZNF365D has eight consensus sites for N/O-glycosylation (asterisks). The Ala62Thr missense
variant found in the ZNF365D isoform is shown (arrow).
substitution (variant Ala62Thr) (fig. 3). Moreover, we
identified a number of polymorphisms in UTR and in-
tronic regions of the gene.
Association analysis was performed in the selected
case-control sample to examine whether the presence of
these alleles conferred increased risk of UAN. Compar-
ison of allelic frequencies in cases and controls showed
strong association between UAN and variant Ala62Thr
( ; empirical ) with a significant in-Pp .0096 Pp .0051
crease in risk (OR 2.73; 95% CI 1.01–7.44). However,
the Ser337Ala variant was not significantly associated.
When we compared haplotype frequencies in cases and
controls who carried the identified variant, we observed
significant evidence of association with UAN for dif-
ferent haplotype windows that included the variant,
whereas a sharp decrease of association was observed
when moving away from the associated site (fig. 6). The
variant Ala62Thr was invariably associated with the 67-
kb core haplotype that confers increased risk. The es-
timated penetrances of Ala62Thr showed an increasing
trend across genotypes (penetrance of Ala/Ala homo-
zygotes 17.6%; penetrance of Ala/Thr heterozygotes
32.3%; penetrance of Thr/Thr homozygotes 44.8%),
thus suggesting that the mutation may be causative.
After the identification of the Ala62Thr mutation, we
investigated the influence of this variant on the linkage
findings. Employing a procedure like the one used by
Hampe et al. (2002) to determine the contributions of
a specific polymorphism to a linkage curve, we per-
formed two complementary analyses by stratifying the
family sample on affected subjects carrying and not car-
rying the variant. Affected subjects who did not have
the selected genotype were coded as “unknown.” For
these analyses, we used a large pedigree comprising 335
subjects and connecting 60 affected individuals (43 car-
rying the variant Ala62Thr and 17 not carrying it).
When we considered only those subjects who carried the
variant to be affected, we found that the evidence of
linkage in the whole region was increased (peak P value
of .0005 for Simwalk2 statistic D), whereas the evidence
for linkage dropped steeply ( for all Simwalk2P 1 .05
statistics on the whole region) when only affected sub-
jects not carrying the variant were considered to be af-
fected, indicating a major influence of Ala62Thr on the
linkage evidence in this region.
Given that some polymorphisms (e.g., a nonsynony-
mous change [missense mutation]) are more likely to
alter the function of a protein, we investigated the pos-
sibility that the high-risk allele ZNF365D (Ala62Thr)
may play a functional role in the UAN phenotype. In-
terestingly, computer-assisted analysis strongly predicted
the secondary structural alteration of the ZNF365D pro-
tein induced by the Ala62Thr variation. Essentially, the
third a-helical loop of the putative UAN-susceptibil-
ity allele (threonine) is not present compared to the not
associated allele (alanine). These results suggest that
threonine causes a significant conformational change
that may have important implications for the biolog-
ical function of this protein or its interaction with
other proteins.
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Figure 5 RT-PCR analysis of the expression of ZNF365A, -B, -C, and- D transcripts in human heart, brain, placenta, lung, liver, skeletal
muscle, kidney, and pancreas. G3PDH (bottom panel) was used as a control gene. The amplified fragments of the ZNF365 transcripts and the
size of the amplifications are shown (right).
Discussion
UAN is a multifactorial disorder influenced by genetics
and environmental factors. The clustering of the disease
in families suggests a predisposing set of genes not yet
characterized. On the other hand, a purine-rich diet and
climatic factors have an equally important role in the
etiology of the disease. Because UAN is a very common
disorder, it must result from many different combinations
of causative risk factors. Identification of groups of pa-
tients sharing the same predisposing genes and environ-
ment in open populations is therefore very difficult. The
study of an isolated population characterized by genetic
and environmental homogeneity presents potential ad-
vantages for mapping genes for common multifactorial
diseases, such as UAN (Wright et al. 1999; Peltonen et
al. 2000). The ideal isolated population should be a large
pedigree with many generations (Jorde et al. 2000), in
which allelic and locus homogeneity is likely to be max-
imized. Indeed, a powerful approach to LD mapping is
the ascertainment of a set of distantly related affected
individuals, which would enrich for genetic forms of mul-
tifactorial diseases and in which a large proportion of
affected individuals are likely to share the same disease-
predisposing allele inherited from common ancestors.
We performed our study in a particularly isolated vil-
lage of a secluded area of east-central Sardinia, in which
80% of the present-day population appears to derive
from 8 paternal and 11 maternal ancestral lineages (An-
gius et al. 2001). All genealogical data, as well as phe-
notypic and genetic data, are stored in relational data-
bases that connect 5,219 individuals in a 16-generation
pedigree. The bioinformatic framework comprises sev-
eral algorithms that select from the database the subjects
most suitable for the analysis.
We found an increased prevalence of UAN cases in
Talana. Many cases cluster in families of varying sizes.
Elsewhere, we reported results of a multistep genome-
wide search in an extended family comprising 37 indi-
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Figure 6 Results of the haplotype-association analysis performed in the selected sample comprising 64 case haplotypes and 82 control
haplotypes. The curves represent the extent of association, expressed as log(p), between UAN and multilocus haplotypes. For two-locus
haplotypes, results are shown for the pair of adjacent markers, and points are drawn at the midpoint between the two. For three-locus haplotypes,
results are shown for combinations of adjacent markers, and points are drawn at the position of the middle marker. Empirical significance was
assessed through Monte Carlo simulations. Only common haplotypes (frequency 15% in the combined sample) were compared.
viduals with UAN, and we identified a susceptibility lo-
cus of ∼2.5 cM on 10q21-q22, with the highest evidence
at marker D10S1652 (Ombra et al. 2001).
In the present study, we selected, on the basis of phe-
notype severity, an additional 62 UAN cases; all were
connected in an extended genealogical tree. Linkage
analysis confirms the involvement of the identified sus-
ceptibility locus. Given the significant evidence, derived
from formal kinship analysis, that UAN cases are more
likely than controls to share all four alleles IBD (i.e., to
be autozygous), we also performed homozygosity map-
ping in our sample of cases. Although homozygosity
mapping is usually performed in the study of rare Men-
delian recessive disorders, it has also been suggested as
a powerful tool for mapping complex disease-predis-
posing genes (even those with minor effects) in inbred,
isolated populations (Broman and Weber 1999).
To detect the causative gene, we constructed a tran-
scriptional map of the 1.1-Mb consensus genomic se-
quence, which corresponds to the identified 2.5-cM
10q21-q22 UAN locus. No obvious candidate genes
were found. We then applied fine-mapping approaches,
to refine the critical region associated with UAN. Since
an increased rate of false-positive results is expected in
an association analysis in which cases are more closely
related than controls, we carefully selected a subsample
by use of the information from the genealogy data. In
the resulting group, cases and controls present the same
degree of relatedness and therefore do not inflate the
significance of the test (Genin and Clerget-Darpoux
1996). We were able to identify a common core hap-
lotype found in excess in cases compared with controls
and to narrow, through multilocus LD analysis, the crit-
ical interval associated with UAN to ∼67 kb, encom-
passing marker D10S1652. This small region was in-
cluded in a 300-kb interval in which we found the novel
gene ZNF365, which encodes at least four different pro-
teins. Although, at present, there is no indication as to
the function of these proteins, one of these isoforms,
which we named “Talanin,” resides entirely within the
67-kb region, representing a strong candidate risk factor
for the disease. Through sequence analysis of the coding
region and most of the introns, we detected several poly-
morphisms and only one coding variant, Ala62Thr, that
provided the strongest evidence of association with UAN
( ) and that segregates the original evidencePp .0051
for linkage to the region. We also obtained significant
evidence of increased homozygosity in the associated
region among affected individuals. This may suggest that
the presence of two copies of the susceptibility allele
would lead to a greater increase in risk of UAN than
would the presence of a single copy, under the assump-
tion that the susceptibility gene has a dosage effect.
The underlying mechanism by which the Ala62Thr
variant confers susceptibility to UAN remains unclear;
however, bioinformatic simulation predicts a change in
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the secondary structure of the protein, since one of the
a-helixes disappears when alanine is changed to threo-
nine. This suggests that the Ala62Thr variant may play
a causative role. For the other polymorphism showing
association with UAN (pSNP3A, which is contained in
intron 9 of the gene), we did not identify a functional
role. Therefore, its association with UAN could be due
to its being in strong LD with Ala62Thr.
It is always difficult to prove the phenotypic effect of
a missense mutation in a protein, such as Talanin, for
which the function is not yet known. Until functional
studies can explain the role of the Ala62Thr variant in
UAN, it will be important to replicate these results in
other populations. Preliminary results in other isolated
villages in the same area of Sardinia indicate that the
same Ala62Thr susceptibility variant is present in 12 of
14 unrelated patients with UAN, compared with 47 of
92 controls ( ). On the other hand, this variantPp .02
is rather common in the general Sardinian population
(frequency 32%).
Together, these results provide convergent evidence for
the interpretation that Ala62Thr may contribute to risk
of UAN. Ala62Thr provided the strongest evidence of
association with UAN, although we cannot exclude the
presence, in the associated interval, of another causative
variant that is in LD with the identified Talanin poly-
morphism. Future genetic and functional studies are nec-
essary to further validate these conclusions.
Our results suggest that Talana villagers and similar
populations can be considered ideal for an efficient and
parsimonious approach to the identification of genetic
risk factors for complex traits. We believe that a study
in which a small number of samples are phenotypically
well characterized and strategically placed on extended
genealogies can challenge studies based on much greater
numbers in outbred populations.
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